Nuvectra Corporation (NASDAQ:NVTR)‘s stock had its “hold” rating reiterated by research analysts at Piper Jaffray Companies in a note issued to investors on Friday. They presently have a $12.00 price objective on the stock. Piper Jaffray Companies’ price target indicates a potential upside of 16.62% from the company’s previous close.

Several other analysts also recently weighed in on NVTR. Zacks Investment Research upgraded shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 12th. ValuEngine downgraded shares of Nuvectra Corporation from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $12.00.

Nuvectra Corporation (NVTR) traded down $3.51 during midday trading on Friday, hitting $10.29. 115,647 shares of the stock traded hands, compared to its average volume of 44,740. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.90 and a quick ratio of 3.50.

Nuvectra Corporation (NASDAQ:NVTR) last issued its quarterly earnings data on Wednesday, November 1st. The company reported ($1.09) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.16) by $0.07. The firm had revenue of $7.60 million for the quarter, compared to the consensus estimate of $8.08 million. Nuvectra Corporation had a negative net margin of 204.19% and a negative return on equity of 68.63%. Nuvectra Corporation’s quarterly revenue was up 100.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.92) EPS. analysts anticipate that Nuvectra Corporation will post -4.77 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/03/nuvectra-corporations-nvtr-hold-rating-reiterated-at-piper-jaffray-companies.html.

In related news, CEO Scott F. Drees purchased 10,000 shares of the company’s stock in a transaction on Friday, August 11th. The shares were bought at an average cost of $11.72 per share, for a total transaction of $117,200.00. Following the transaction, the chief executive officer now owns 125,180 shares of the company’s stock, valued at $1,467,109.60. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.60% of the stock is currently owned by insiders.

Several hedge funds have recently added to or reduced their stakes in the business. Wells Fargo & Company MN raised its position in shares of Nuvectra Corporation by 0.7% during the 1st quarter. Wells Fargo & Company MN now owns 112,997 shares of the company’s stock worth $772,000 after buying an additional 751 shares in the last quarter. Gamco Investors INC. ET AL raised its holdings in shares of Nuvectra Corporation by 4.2% in the 2nd quarter. Gamco Investors INC. ET AL now owns 35,194 shares of the company’s stock worth $467,000 after purchasing an additional 1,434 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Nuvectra Corporation by 6.2% in the 2nd quarter. Stifel Financial Corp now owns 34,227 shares of the company’s stock worth $444,000 after purchasing an additional 1,999 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Nuvectra Corporation by 1.7% in the 2nd quarter. Northern Trust Corp now owns 169,659 shares of the company’s stock worth $2,253,000 after purchasing an additional 2,811 shares in the last quarter. Finally, Rockefeller Financial Services Inc. raised its holdings in shares of Nuvectra Corporation by 3.2% in the 2nd quarter. Rockefeller Financial Services Inc. now owns 107,523 shares of the company’s stock worth $1,428,000 after purchasing an additional 3,338 shares in the last quarter. Institutional investors own 57.26% of the company’s stock.

About Nuvectra Corporation

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.